Adverum Biotechnologies Funding & Investors
Redwood City, CA
Adverum Biotechnologies, formerly known as Avalanche Biotechnologies, is a publicly traded (NASDAQ:ADVM) clinical stage gene therapy company located in Redwood City, California. The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME).
adverum.comTotal Amount Raised: $814,872,576
Adverum Biotechnologies Funding Rounds
Post Ipo Equity
$127,500,000
Post Ipo Equity Investors
TCG Crossover ManagementSamsara BioCapitalFrazier Life Sciences ManagementLogos Global ManagementCommodore CapitalVenrock Healthcare Capital PartnersVivo Capital5am VenturesPost Ipo Equity
$217,000,000
Post Ipo Equity
$150,218,750
Post Ipo Equity
$69,000,000
Post Ipo Equity
$50,000,000
Post Ipo Equity
$130,500,000
Post Ipo Equity
$9,999,995
Series B
$55,000,000
Series B Investors
VenrockDeerfield ManagementAdage Capital ManagementRedmile GroupRock Springs CapitalSabby CapitalIPO
Unknown
Series Unknown
$5,653,890
Funding info provided by Diffbot.